Previous Article | Next Article 
Applied and Environmental Microbiology, June 2002, p. 3166-3168, Vol. 68, No. 6
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.6.3166-3168.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Oral Treatment with Lactococcus lactis Expressing Staphylococcus hyicus Lipase Enhances Lipid Digestion in Pigs with Induced Pancreatic Insufficiency
Sophie Drouault,1 Catherine Juste,1 Philippe Marteau,2 Pierre Renault,3 and Gérard Corthier1*
Unité d'Ecologie et de Physiologie du Systeme Digestif,1
Unité de Génétique Microbienne, Institut National de la Recherche Agronomique, 78350 Jouy en Josas,3
Service de Gastroentérologie, Hôpital G. Pompidou, 75908 Paris, France2
Received 3 October 2001/
Accepted 30 March 2002

ABSTRACT
The
Staphylococcus hyicus lip gene was cloned in
Lactococcus lactis. Pancreatic insufficiency was induced by ligation of
the pancreatic duct in pigs. In pigs who had undergone pancreatic
ligation, the coefficient of fat absorption was higher after
consumption of lipase-expressing
L. lactis (91.9% ± 3.7%)
than that after consumption of the inactive control strain (78.4%
± 2.4%).

INTRODUCTION
The efficiency of pancreatic enzyme formulations used to treat
pancreatic insufficiency is often unsatisfactory. Researchers
are therefore trying to find new sources of lipases and new
delivery vehicles (
10). It was shown in a previous study that
Lactococcus lactis was able to secrete the bacterial lipase
of
Staphylococcus hyicus (
5). The aim of this study was to determine
the effectiveness of genetically engineered
L. lactis cells
expressing the bacterial lipase of
S. hyicus to help lipid digestion
in pigs with induced pancreatic insufficiency.
L. lactis and thermoresistant spores of Bacillus subtilis were grown and enumerated as previously described (3, 6). Chloramphenicol and erythromycin (Merck) at a concentration of 10 µg/ml, rifampin at 50 µg/ml, streptomycin (Research Organics Inc.) at 1,000 µg/ml, and nisin powder (2.5% nisin content; ICN International) at 0.5 µg/ml were used. Basic methods for L. lactis genetic modification have been described previously (5). The L. lactis subsp. cremoris strain NZ9000 used in this study was derived from strain MG1363 and contained the genes pepN::nisRnisK (4). To obtain streptomycin- and rifampin-resistant L. lactis (strains JIM7017 and JIM7600), the strains were plated successively onto M17 agar containing 1,000 µg of streptomycin/ml and then onto agar containing 50 µg of rifampin/ml. Strain JIM7017 was the control strain, devoid of the lip gene.

Expression of the S. hyicus lip gene in L. lactis.
pJIM2093 (
5) was amplified by PCR with the oligonucleotides
5'-AATCTTTTGTACC
C ATGGTGAGTGCCTC-3' and 5'-GGGGGCGTGGCAGGC
C ATG GATTCG-3'. The bases in boldface indicate the mutations
inserted in order to create an
NcoI site (in italics) and to
delete the signal peptide encoding sequence. The PCR fragment
was digested by
NcoI and ligated. The resulting plasmid, pJIM2095,
carried the
lip gene without its signal peptide encoding sequence.
It was transformed in
L. lactis NZ9000 (
4) to yield JIM7600.
Lipase expression was induced with a nisin concentration optimal for heterologous protein expression in L. lactis (5). An overnight culture was used to inoculate fresh M17 medium. When an optical density at 600 nm of 0.3 was reached, we added the nisin and followed lipase expression in the cell extracts by Western blotting of the proteins (carried out as previously described [8]) with an anti-lipase serum (5) (Fig. 1). The lipase production was maximal 2 h after nisin induction and was still stable 5 h after induction. We found that lipase represented about 15% of the proteins of the cell (data not shown; scanning gel stained with Coomassie blue).

Pancreatic duct ligation.
To perform pancreatic duct ligation (PDL), pigs were deprived
of food for 24 h before surgery. After a right lateral laparotomy
under halothane anesthesia, two ligatures were placed close
to each other around the pancreatic duct at about 0.5 cm from
the duodenum (
1). The duct was then cut between the ligatures.
After surgery, the pigs were housed in individual cages and
their dietary intake was progressively restored to two daily
meals of 800 g each (300 g of food mixed with 500 ml of water)
at 10 am and 4 pm.

Fate of L. lactis in the digestive tract.
Conventional pigs as well as the pigs with PDL receive 500 ml
of a concentrated culture of
L. lactis prepared as follows.
A 3-liter overnight culture was centrifuged for 10 min at 6,000
x g at 30°C. The bacterial pellet was resuspended in 500
ml of fresh M17 medium mixed with
B. subtilis spores and 1.5
mg of nisin. The final mixture obtained, mixed with the powdered
diet, contained 9.4
x 10
9 ± 0.4
L. lactis cells/g and
9.4
x 10
9 ± 0.3
B. subtilis spores/g. Two hours after
the beginning of their meal, the animals were anesthetized with
halothane. After a right lateral laparotomy, each nonempty part
of the small intestine containing the diet was ligated. The
duodenum was always empty. The contents of the intestine between
the jejunum and the ileum were removed. The stomach and cecum
contents were homogenized, and samples were collected. Before
slaughtering the pigs, we verified that the pancreatic tissue
of the pigs receiving ligation was atrophied and that the pancreatic
duct was dilated. The fecal samples were weighed, homogenized,
and diluted (1/10) in sterile water.
L. lactis and
B. subtilis counts were measured from these dilutions for each sample. Pigs
with or without PDL received the control
L. lactis strain JIM7017
(Fig.
2). The survival of
L. lactis in the stomach and the upper
parts of the jejunum was low for the two groups of pigs but
higher after PDL. In the mid-jejuno-ileum (parts 2 and 3), its
survival did not differ between pigs with or without PDL.

Treatment of induced pancreatic insufficiency with L. lactis expressing the S. hyicus lip gene.
The treatment of induced pancreatic insufficiency with
L. lactis expressing
S. hyicus lip was carried out on four pigs with PDL
(Table
1; PDL occurred at day zero). The pigs were adapted to
receive a high-fat diet (containing 15% lipids). To determine
the efficiency of
L. lactis expressing the
S. hyicus lipase
(JIM7600), the four pigs with PDL were fed the high-fat diet
as two daily meals of 300 g each mixed with 500 ml of a concentrated
culture of
L. lactis JIM7600 or a negative
L. lactis control
(JIM7017). These concentrated cultures were prepared as described
above. The pigs served as their own controls. They received
both strains for 4 days each, interrupted by a 10-day washout
period (strains at days 21 to 24 and then at days 35 to 38).
The stools were collected twice per day over each 4-day period
of bacterial treatment. Stools were immediately frozen. Fecal
and dietary fats were measured (
7), and the coefficient of fat
absorption (CFA) was calculated as the difference between ingested
and excreted fats, which yielded the percentage of ingested
fat (
2). Results are expressed as means with their standard
errors. Values were compared by analysis of variance using SAS
software. The CFA in normal pigs was 97% ± 2%. CFAs from
the results obtained during the two treatment periods are shown
in Table
1. The CFA was enhanced in all animals when the pigs
ingested the strain producing lipase (91.9% ± 3.7%) compared
to when they ingested the inactive strain (78.4% ± 2.4%),
and the difference between both periods was significant (
P <
0.01).
The aim of the present study was to test the hypothesis that
lactic acid bacteria expressing an heterologous lipase were
efficient in reducing induced pancreatic insufficiency. We induced
exocrine pancreatic insufficiency in pigs through PDL. A recent
experimental study in dogs suggested that an acid- and protease-resistant
lipase of bacterial origin might improve fat absorption (
10,
11). Since lactococci are rapidly destroyed by bile acids and
proteolytic secretions (
6,
9), we hypothesized that lactococci
genetically modified to have a high production of a bacterial
lipase could be used as a vector instead of the pure enzyme.
It was previously shown that
S. hyicus lipase could be produced
in
L. lactis (
5). In this study, we improved the lipase production
by removing the initial peptide signal encoding sequence necessary
for secretion.
In pigs with or without PDL, the majority of ingested L. lactis cells lost their viability in the upper jejuno-ileum. It was previously shown that dead L. lactis released its cellular content in the digestive tracts of mice (6). We have shown that in the four pigs with PDL, L. lactis producing lipase could correct steatorrhea when ingested with a high-lipid meal. The CFA showed significant improvement over the treatment period compared to that obtained under the period of treatment with lipase-devoid L. lactis. We conclude that lactic acid bacteria, such as L. lactis modified to express lipase, could be used as a new vector to deliver lipase in the gastrointestinal tract. This is potentially a major advancement in the treatment of pancreatic insufficiency in humans. The cost and safety of such a treatment also seems promising.

ACKNOWLEDGMENTS
We are grateful to T. Corring for helpful advice, to C. Gibard
for lipid analyses in food and feces, to F. Cointpas and F.
Gérard, to D. Besnard and M.-G. Brachet for pig surgery
and animal management, and to P. Rapine for technical assistance.

FOOTNOTES
* Corresponding author. Mailing address: Unité d'Ecologie et de Physiologie du Systeme digestif, Institut National de la Recherche Agronomique, Batiment 440, 78352 Jouy en Josas Cedex, France. Phone: 33-1 34 65 24 67. Fax: 33-1 34 65 24 62. E-mail:
corthier{at}jouy.inra.fr.


REFERENCES
1 - Corring, T. C., A. Aumaitre, and A. Rerat. 1972. Permanent fistulization of the exocrine pancreas in the pig. Application: response of pancreatic secretion to feeding. Ann. Biol. Anim. Biochim. Biophys. 12:109-124.[Medline]
2 - Corring, T. C., C. Juste, C. Simoes-Nunes, and D. Bourdon. 1979. Effect of biliary secretion on digestion in the pig. Ann. Biol. Anim. Biochim. Biophys. 19:1123-1130.
3 - Corthier, G., C. Delorme, S. D. Ehrlich, and P. Renault. 1998. Use of luciferase genes as biosensors to study bacterial physiology in the digestive tract. Appl. Environ. Microbiol. 64:2721-2722.[Abstract/Free Full Text]
4 - de Ruyter, P. G., O. P. Kuipers, and W. M. de Vos. 1996. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 62:3662-3667.[Abstract]
5 - Drouault, S., G. Corthier, S. D. Ehrlich, and P. Renault. 2000. Expression of the Staphylococcus hyicus lipase in Lactococcus lactis. Appl. Environ. Microbiol. 66:588-598.[Abstract/Free Full Text]
6 - Drouault, S., G. Corthier, S. D. Ehrlich, and P. Renault. 1999. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl. Environ. Microbiol. 65:4881-4886.[Abstract/Free Full Text]
7 - Folch, J., and M. Lees. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.[Free Full Text]
8 - Le Loir, Y., A. Gruss, S. D. Ehrlich, and P. Langella. 1998. A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis. J. Bacteriol. 180:1895-1903.[Abstract/Free Full Text]
9 - Marteau, P., M. Minekus, R. Havenaar, and J. H. Huis in't Veld. 1997. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J. Dairy Sci. 80:1031-1037.[Abstract]
10 - Suzuki, A., A. Mizumoto, R. Rerknimitr, M. G. Sarr, and E. P. DiMango. 1999. Effect of bacterial or porcine lipase with low- or high-fat diets on nutrient absorption in pancreatic-insufficient dogs. Gastroenterology 116:431-437.[CrossRef][Medline]
11 - Suzuki, A., A. Mizumoto, M. G. Sarr, and E. P. DiMagno. 1997. Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea? Gastroenterology 112:2048-2055.[CrossRef][Medline]
Applied and Environmental Microbiology, June 2002, p. 3166-3168, Vol. 68, No. 6
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.6.3166-3168.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Balcazar, J.L.
(2007). Probiotics in health maintenance: do they really work?. British Journal of Infection Control
8: 26-29
[Abstract]
-
Garrait, G., Jarrige, J. F., Blanquet, S., Beyssac, E., Alric, M.
(2007). Recombinant Saccharomyces cerevisiae Strain Expressing a Model Cytochrome P450 in the Rat Digestive Environment: Viability and Bioconversion Activity. Appl. Environ. Microbiol.
73: 3566-3574
[Abstract]
[Full Text]
-
Corthesy, B., Gaskins, H. R., Mercenier, A.
(2007). Cross-Talk between Probiotic Bacteria and the Host Immune System. J. Nutr.
137: 781S-790S
[Abstract]
[Full Text]
-
Marteau, P
(2006). Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?. Gut
55: 1692-1693
[Full Text]
-
Monedero, V., Rodriguez-Diaz, J., Viana, R., Buesa, J., Perez-Martinez, G.
(2004). Selection of Single-Chain Antibodies against the VP8* Subunit of Rotavirus VP4 Outer Capsid Protein and Their Expression in Lactobacillus casei. Appl. Environ. Microbiol.
70: 6936-6939
[Abstract]
[Full Text]